Preconditioning of skeletal myoblast-based engineered tissue constructs enables functional coupling to myocardium in vivo

Abstract

Objective Skeletal myoblasts fuse to form functional syncytial myotubes as an integral part of the skeletal muscle. During this differentiation process, expression of proteins for mechanical and electrical integration is seized, which is a major drawback for the application of skeletal myoblasts in cardiac regenerative cell therapy, because global heart function depends on intercellular communication. Methods Mechanically preconditioned engineered tissue constructs containing neonatal mouse skeletal myoblasts were transplanted epicardially. A Y-chromosomal specific polymerase chain reaction (PCR) was undertaken up to 10 weeks after transplantation to confirm the presence of grafted cells. Histologic and electrophysiologic analyses were carried out 1 week after transplantation. Results Cells within the grafted construct expressed connexin 43 at the interface to the host myocardium, indicating electrical coupling, confirmed by sharp electrode recordings. Analyses of the maximum stimulation frequency (5.65 ± 0.37 Hz), conduction velocity (0.087 ± 0.011 m/s) and sensitivity for pharmacologic conduction block (0.736 ± 0.080 mM 1-heptanol) revealed effective electrophysiologic coupling between graft and host cells, although significantly less robust than in native myocardial tissue (maximum stimulation frequency, 11.616 ± 0.238 Hz, P<.001; conduction velocity, 0.300 ± 0.057 m/s, P<.01; conduction block, 1.983 ± 0.077 mM 1-heptanol, P<.001). Conclusions Although untreated skeletal myoblasts cannot couple to cardiomyocytes, we confirm that mechanical preconditioning enables transplanted skeletal myoblasts to functionally interact with cardio-myocytes in vivo and, thus, reinvigorate the concept of skeletal myoblast-based cardiac cell therapy.

Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium

“…6–9 Our lab and others have demonstrated that endothelial progenitor cells (EPCs) are easily expanded in vitro and have the ability to engraft and improve cardiac function and attenuate ventricular remodeling when delivered after infarction. 10–14 …”

Electromechanical Conditioning of Adult Progenitor Cells Improves Recovery of Cardiac Function After Myocardial Infarction

“…Although individual electrical or mechanical cellular conditioning has been tested previously in vivo [, ], this work is the first to combine electrical and mechanical conditioning simultaneously for adipose tissue progenitor cells and use them for therapeutic purposes. Indeed, simultaneous electrical and mechanical stimulation have previously only been analyzed in vitro [, , ], and this report is the first to study its beneficial effects at the in vivo physiological level.…”

Arrhythmogenic risks of stem cell replacement therapy for cardiovascular diseases

“…Since Cx43 + gap junctions between SkMs and host cardiomyocytes are not detected in injured hearts after transplantation of SkMs, they are unable to form any electromechanical junctions with the native myocardium, resulting in slowed conduction and induced arrhythmia after SkM transplantation (Reinecke, MacDonald, Hauschka, & Murry, 2000). Advancing electromechanical coupling by hyperthermia or mechanically preconditioned by engineered tissue constructs may improve Cx43 expression in SkMs and couple to host cardiomyocytes (Antanavičiūtė, Mildažienė, Stankevičius, Herdegen, & Skeberdis, 2014; Treskes et al, 2015). Low cardiac excitability of transplanted cells: Cardiac excitability generates an AP at cardiomyocytes membrane in response to depolarization and to transmit an impulse along the membrane.…”